Zydus Lifesciences joins hands with CVS Caremark for diabetes drugs template formulary

Zydus Lifesciences Ltd enters an agreement with CVS Caremark to add Zituvio, Zituvimet, and Zituvimet XR tablets for diabetes treatment to CVS’s template formulary starting January 1, 2025. This collaboration validates Zydus' new drug applications portfolio and aims to improve access to high-quality medications for patients.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/VI0DlNE
via IFTTT